Literature DB >> 21284092

Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine.

Rosa Artells1, Alfons Navarro, Tània Diaz, Mariano Monzó.   

Abstract

Intestinal myofibroblasts (IMFs), also known as pericryptal fibroblasts, are found at the basement membrane of the intestinal epithelium. They are characterized by well-developed endoplasmic reticulum, cytoplasmic fibers, and fibrous extensions called fibronexi. IMFs have structural features in common both with fibroblasts and smooth cells. Vimentin, desmin, and α-smooth-muscle actin (α-SM) are markers commonly used to discriminate between IMFs and smooth muscle cells. Immunohistochemical studies have shown that, when α-SM and vimentin are positive in both IMFs and smooth muscle cells, desmin is negative in IMFs but positive in smooth muscle cells. In the adult intestine, IMFs play an important role in various functions, especially in tissue repair and scar formation during wound healing. In the embryonic intestine, however, wound healing does not occur, and to date, no studies have investigated the first appearance and subsequent evolution of IMFs. In this study, we have examined the human small intestine in embryos at 7, 9, and 11 weeks of development by ultrastructural and immunohistochemical analysis to shed light on the formation of IMFs during these early phases of organogenesis. At 7 weeks, the embryonic mesenchymal cells are similar to proto-myofibroblasts and may be the precursors of the IMFs detected at 9 weeks and more abundantly at 11 weeks by immunohistochemistry. These IMFs seem to mediate information flow between the epithelium and the mesenchyme and thus contribute to the development of the small intestine.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284092     DOI: 10.1002/ar.21333

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  7 in total

1.  Compression garments to prevent delayed onset muscle soreness in soccer players.

Authors:  Xavier Valle; Lluís Til; Franchek Drobnic; Antonio Turmo; José Bruno Montoro; Oliver Valero; Rosa Artells
Journal:  Muscles Ligaments Tendons J       Date:  2014-02-24

2.  Reduction of delayed onset muscle soreness by a novel curcumin delivery system (Meriva®): a randomised, placebo-controlled trial.

Authors:  Franchek Drobnic; Joan Riera; Giovanni Appendino; Stefano Togni; Federico Franceschi; Xavier Valle; Antoni Pons; Josep Tur
Journal:  J Int Soc Sports Nutr       Date:  2014-06-18       Impact factor: 5.150

3.  The significance of PIWI family expression in human lung embryogenesis and non-small cell lung cancer.

Authors:  Alfons Navarro; Rut Tejero; Nuria Viñolas; Anna Cordeiro; Ramon M Marrades; Dolors Fuster; Oriol Caritg; Jorge Moises; Carmen Muñoz; Laureano Molins; Josep Ramirez; Mariano Monzo
Journal:  Oncotarget       Date:  2015-10-13

4.  PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.

Authors:  Anna Cordeiro; Alfons Navarro; Anna Gaya; Marina Díaz-Beyá; Blanca Gonzalez-Farré; Joan Josep Castellano; Dolors Fuster; Carmen Martínez; Antonio Martínez; Mariano Monzó
Journal:  Oncotarget       Date:  2016-07-19

5.  MicroRNA-200 families and prognostic value in various carcinomas: A systematic review and meta-analysis.

Authors:  Yuan Yin; Wei Wei Song; Yu Wang; Weihong Zhao; Jianqing Wu; Wei Xu
Journal:  Aging Med (Milton)       Date:  2018-02-07

6.  miR-141 and miR-200c as markers of overall survival in early stage non-small cell lung cancer adenocarcinoma.

Authors:  Rut Tejero; Alfons Navarro; Marc Campayo; Nuria Viñolas; Ramon M Marrades; Anna Cordeiro; Marc Ruíz-Martínez; Sandra Santasusagna; Laureano Molins; Josep Ramirez; Mariano Monzó
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

7.  PDGFRα+ pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo.

Authors:  Gediminas Greicius; Zahra Kabiri; Kristmundur Sigmundsson; Chao Liang; Ralph Bunte; Manvendra K Singh; David M Virshup
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-20       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.